Theo Strauven

Stratified phase II trial of cetuximab in patients with recurrent high-grade glioma

Bart Neyns, Jan Sadones, E. Joosens et al. · Annals of Oncology · 2009 · 240 citations · Full text

Medicine, Oncology, Pharmacology +14

MGMT promoter hypermethylation correlates with a survival benefit from temozolomide in patients with recurrent anaplastic astrocytoma but not glioblastoma

Jan Sadones, Alex Michotte, Pieter In 'T Veld et al. · European Journal of Cancer · 2008 · 54 citations

Medicine, Cancer Biology, Oncology +15

First case of anti-ganglioside GM1-positive Guillain–Barré syndrome due to hepatitis E virus infection

I. Maurissen, A Jeurissen, Theo Strauven et al. · Infection · 2011 · 53 citations

Life Sciences, Infectious Diseases, Neurology +13

Temozolomide for the Treatment of Recurrent Supratentorial Glioma: Results of a Compassionate use Program in Belgium

Els Everaert, Bart Neyns, E. Joosens et al. · Journal of Neuro-Oncology · 2004 · 15 citations

Medicine, Neurosurgery, Oncology +13

A Multicenter Stratified Phase Ii Study of Cetuximab for the Treatment of Patients With Recurrent High-grade Glioma

Bart Neyns, Jan Sadones, E. Joosens et al. · Digital Access to Libraries (Université catholique de Louvain (UCL), l'Université de Namur (UNamur) and the Université Saint-Louis (USL-B)) · 2008 · 10 citations · Full text

Medicine, Oncology, Pharmacology +14